Pacific Biosciences of California, Inc. (BMV:PACB)

Mexico flag Mexico · Delayed Price · Currency is MXN
22.22
0.00 (0.00%)
At close: May 14, 2025
Market Cap 6.84B
Revenue (ttm) 3.11B
Net Income (ttm) -13.44B
Shares Out n/a
EPS (ttm) -47.89
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,889
Average Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range 22.22 - 22.22
Beta n/a
RSI n/a
Earnings Date Aug 7, 2025

About BMV:PACB

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified ... [Read more]

Industry Laboratory Analytical Instruments
Founded 2000
Employees 575
Stock Exchange Mexican Stock Exchange
Ticker Symbol PACB
Full Company Profile

Financial Performance

In 2024, BMV:PACB's revenue was $154.01 million, a decrease of -23.19% compared to the previous year's $200.52 million. Losses were -$309.85 million, 1.02% more than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.